EICHORCondition: Breast Cancer · Breast Tumors · Metastatic Cancer · Sponsor: NantCell, Inc.
This is a randomized, double-blind, placebo-controlled, phase 2 study. Subjects will include postmenopausal women with confirmed HR-positive, locally advanced or metastatic breast cancer, who have disease progression during or within 12 months after completing prior adjuvant endocrine therapy or during the first prior endocrine therapy for metastatic disease.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Research Site | Chandler, Arizona, United States | — |
| Research Site | Anaheim, California, United States | — |
| Research Site | Beverly Hills, California, United States | — |
| Research Site | Concord, California, United States | — |
| Research Site | Duarte, California, United States | — |
| Research Site | Montebello, California, United States | — |
| Research Site | San Francisco, California, United States | — |
| Research Site | Sylmar, California, United States | — |
| Research Site | Stamford, Connecticut, United States | — |
| Research Site | Boca Raton, Florida, United States | — |
| Research Site | Boynton Beach, Florida, United States | — |
| Research Site | Coral Springs, Florida, United States | — |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00626106